Nanjing Vishee Medical Technology Management
Management criteria checks 3/4
Nanjing Vishee Medical Technology's CEO is Zhiyu Wang, appointed in Nov 2021, has a tenure of 3.17 years. directly owns 39.77% of the company’s shares, worth CN¥1.01B. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.
Key information
Zhiyu Wang
Chief executive officer
CN¥1.7m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.2yrs |
| CEO ownership | 39.8% |
| Management average tenure | 3.2yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
Nanjing Vishee Medical Technology (SHSE:688580) Will Want To Turn Around Its Return Trends
Dec 17
Earnings Troubles May Signal Larger Issues for Nanjing Vishee Medical Technology (SHSE:688580) Shareholders
Nov 01Nanjing Vishee Medical Technology Co., Ltd's (SHSE:688580) Shares Leap 35% Yet They're Still Not Telling The Full Story
Oct 07Nanjing Vishee Medical Technology (SHSE:688580) Is Reinvesting At Lower Rates Of Return
Aug 23Investors Don't See Light At End Of Nanjing Vishee Medical Technology Co., Ltd's (SHSE:688580) Tunnel
Jun 06Solid Earnings May Not Tell The Whole Story For Nanjing Vishee Medical Technology (SHSE:688580)
May 02Nanjing Vishee Medical Technology Co., Ltd (SHSE:688580) Shares Fly 30% But Investors Aren't Buying For Growth
Mar 06Nanjing Vishee Medical Technology Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 29CEO
Zhiyu Wang (57 yo)
3.2yrs
Tenure
CN¥1,729,700
Compensation
Mr. Zhiyu Wang serves as General Manager & Chairman of the Board and General Manager at Nanjing Vishee Medical Technology Co., Ltd. since November 2021.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman of the Board | 3.2yrs | CN¥1.73m | 39.77% CN¥ 1.0b | |
| CFO, Accounting Supervisor & Director | 3.2yrs | CN¥735.90k | 0.032% CN¥ 819.2k | |
| Chief Operating Officer | 3.2yrs | CN¥797.30k | 0.10% CN¥ 2.7m | |
| Marketing Director | 7.6yrs | CN¥636.30k | no data | |
| Deputy GM & Director | 3.2yrs | no data | no data | |
| Deputy GM & Secretary | 3.2yrs | CN¥726.50k | 0.036% CN¥ 913.0k | |
| Deputy General Manager | 3.2yrs | CN¥833.70k | 0.12% CN¥ 3.1m | |
| R&D Director and Core Technician | 9.6yrs | CN¥678.70k | no data |
3.2yrs
Average Tenure
43.5yo
Average Age
Experienced Management: 688580's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman of the Board | 3.2yrs | CN¥1.73m | 39.77% CN¥ 1.0b | |
| CFO, Accounting Supervisor & Director | 3.2yrs | CN¥735.90k | 0.032% CN¥ 819.2k | |
| Deputy GM & Director | 3.2yrs | no data | no data | |
| Chairman of the Supervisory Board | 3.2yrs | no data | 16.54% CN¥ 420.5m | |
| Independent Director | 3.2yrs | CN¥80.00k | no data | |
| Independent Director | 3.2yrs | CN¥80.00k | no data | |
| Member of Supervisory Board | 3.2yrs | no data | no data | |
| Director | 3.2yrs | no data | 0.25% CN¥ 6.5m | |
| Independent Director | 1.7yrs | CN¥50.00k | no data |
3.2yrs
Average Tenure
45yo
Average Age
Experienced Board: 688580's board of directors are considered experienced (3.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/06 22:21 |
| End of Day Share Price | 2025/01/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nanjing Vishee Medical Technology Co., Ltd is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yanyin Zhu | China International Capital Corporation Limited |
| Xipeng Feng | China International Capital Corporation Limited |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |